nimodipine has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Webb, AJ | 1 |
| Gillies, MJ | 1 |
| Cadoux-Hudson, TA | 1 |
| Hoa, NK | 1 |
| Norberg, A | 1 |
| Sillard, R | 1 |
| Van Phan, D | 1 |
| Thuan, ND | 1 |
| Dzung, DT | 1 |
| Jörnvall, H | 1 |
| Ostenson, CG | 1 |
| Mück, W | 1 |
| Heine, PR | 1 |
| Breuel, HP | 1 |
| Niklaus, H | 1 |
| Horkulak, J | 1 |
| Ahr, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gynostemma Pentaphyllum Tea Improves Insulin Sensitivity in Type 2 Diabetic Patients[NCT01254084] | Phase 1/Phase 2 | 16 participants (Actual) | Interventional | 2010-02-28 | Completed | ||
| Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients[NCT00808860] | Phase 1/Phase 2 | 25 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic Patients[NCT00786500] | Phase 1/Phase 2 | 24 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for nimodipine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The effect of multiple oral dosing of nimodipine on glibenclamide pharmacodynamics and pharmacokinetics in elderly patients with type-2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Interactions | 1995 |
2 other studies available for nimodipine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Acute vasospasm following transcallosal resection of a xanthogranulomatous colloid cyst of the 3rd ventricle.
Topics: Angioplasty; Calcium Channel Blockers; Central Nervous System Cysts; Cerebral Angiography; Cerebral | 2010 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |
The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; D | 2007 |